|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/2809 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 14/78 | (2006.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K 16/30 | (2006.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C07K2317/32 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C12N 15/62 | (2006.01) | ||
| C07K 16/18 | (2013.01) | ||
| C07K 16/2833 | (2013.01) | ||
| C07K 16/30 | (2013.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C07K 14/78 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K2319/33 | (2013.01) | ||
| C12N 5/0636 | (2013.01) | ||
| C12N 15/62 | (2013.01) | ||
| C12N2510/00 | (2013.01) |
| (11) | Number of the document | 3707159 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18803349.2 |
| Date of filing the European patent application | 2018-11-05 | |
| (97) | Date of publication of the European application | 2020-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/080176 |
| Date | 2018-11-05 |
| (87) | Number | WO 2019/086665 |
| Date | 2019-05-09 |
| (30) | Number | Date | Country code |
| 102017125888 | 2017-11-06 | DE | |
| 201762582202 P | 2017-11-06 | US |
| (72) |
UNVERDORBEN, Felix , DE
BUNK, Sebastian , DE
HOFMANN, Martin , DE
HUTT, Meike , DE
MAURER, Dominik , DE
ALTEN, Leonie , DE
WAGNER, Claudia , DE
|
| (73) |
Immatics Biotechnologies GmbH ,
Paul-Ehrlich-Strasse 15, 72076 Tübingen,
DE
|
| (54) | NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME |
| NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME |